...
首页> 外文期刊>Asian Journal of Microbiology, Biotechnology and Environmental Science >EVALUATION OF ANTI-DIABETIC ACTIVITY OF ACHYRANTHES ASPERA IN ALLOXAN INDUCED DIABETIC RATS
【24h】

EVALUATION OF ANTI-DIABETIC ACTIVITY OF ACHYRANTHES ASPERA IN ALLOXAN INDUCED DIABETIC RATS

机译:紫杉醇对四氧嘧啶致糖尿病大鼠抗糖尿病活性的评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the present study the anti-diabetic activity of A. aspera was evaluated. In Wister albino mice the diabetic state was induced by intraperitonial injection of alloxan at a dose of 100 mg/kg of body weight. Animals fasting blood glucose levels were evaluated and above 200 mg/dl were considered as diabetic and used to screen the anti diabetic effect of A. aspera. Animals were grouped into normal mice (Control), diabetic mice (alloxan), diabetic but extract treated mice, only extract treated mice anddiabetic but standard anti-diabetic drug tolbutamide treated mice groups. Animals were screened for the parameters such as body weight, blood glucose level, total proteins, cholesterol and enzyme levels such as AST, ALT and ALP for deducing the anti-diabetic activity of the test plant. The alloxan treated mice shows reduced body (26%) and liver (40%) weight. The plant extract plays role in maintaining the liver weight as in case of normal but no much contribution towards body weight. The blood glucose level falls by 48% with extract introduction, demonstrating the anti-diabetic potential of the plant. The serum enzymes AST and ALT were increased 30 IU/1, 20 IU/1 from 60 IU/1, 65 IU/1 respectively whereas ALP was decreased to 6 IU/1 from 14 IU/1. The total serum protein level also increased up to 5 mg/ml in the extract treated animal. The insulin level also increased up to 81 mu g /ml within 30 days of extract treatment compared to control with 51mu g/mL. The plant extract efficiently decreased the initial cholesterol 219 mu g/mL level intol51 ug/mL. In liver the AST, ALT and ALP enzymes were decreased to 160 IU/1, 60 IU/1,140 IU/1 from 178 IU/mL, 79 IU/mL and 156 IU/mL respectively.
机译:在本研究中,评估了曲霉曲霉的抗糖尿病活性。在Wister白化病小鼠中,通过腹膜内注射四氧嘧啶以100 mg / kg体重的剂量诱导糖尿病状态。评价空腹血糖水平的动物,将高于200mg / dl的动物视为糖尿病,并用于筛选曲霉菌的抗糖尿病作用。将动物分为正常小鼠(对照),糖尿病小鼠(四氧嘧啶),糖尿病但提取物治疗的小鼠,仅提取物治疗的小鼠和糖尿病但标准的抗糖尿病药物甲苯磺丁胺治疗的小鼠组。筛选动物的参数,例如体重,血糖水平,总蛋白,胆固醇和酶水平,例如AST,ALT和ALP,以推论试验植物的抗糖尿病活性。经四氧嘧啶处理的小鼠体重减轻(26%),肝脏重量减轻(40%)。与正常情况一样,植物提取物在维持肝脏重量方面起着作用,但对体重的贡献不大。引入提取物后,血糖水平下降了48%,表明该植物具有抗糖尿病的潜力。血清酶AST和ALT从60 IU / 1、65 IU / 1分别增加了30 IU / 1、20 IU / 1,而ALP从14 IU / 1降低到了6 IU / 1。在提取物治疗的动物中,总血清蛋白水平也增加至5 mg / ml。与51μg/ mL的对照相比,在提取物处理的30天内,胰岛素水平也增加至高达81μg/ ml。该植物提取物有效地将初始胆固醇219μg/ mL降低至151μg/ mL。在肝脏中,AST,ALT和ALP酶分别从178 IU / mL,79 IU / mL和156 IU / mL降至160 IU / 1、60 IU / 1,140 IU / 1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号